Bio

Rik joined RCC in 2004 and leads the HCIT practice while supporting Medical Device. Prior to his private equity career, Rik gained experience working with venture backed companies in the strategy group of Scient, a global eBusiness consulting firm. Before Scient, Rik worked for four years at Accenture, first in the healthcare services group and then at the Internet Center of Excellence where he helped launch several venture-backed companies as well as worked on the team that developed the online music platform for BestBuy. Rik serves on the boards of Netsertive and Continuity and as an observer on the board of Liquibase. He was previously on the board of BardyDx, which sold to Hillrom in 2021; Veran Medical, which sold to Olympus; APS, which sold to Relias Learning in 2016; EndoChoice, which had an IPO in 2015 (NYSE: GI) and sold to Boston Scientific (NYSE: BSX) in 2016; an observer on the board of Pioneer Surgical, which sold to RTI Surgical (Nasdaq: RTIX) in 2013; and on the board of Fullscope (sold to Edgewater (Nasdaq: EDGW) in 2009. Rik graduated from Vanderbilt University where he received his BE in Mechanical Engineering, and he received an MBA from Duke University.